As the specific impact of changes in tumor size on a possible change in VA has not been studied comprehensively, this is, to our knowledge, the first analysis evaluating the impact of calculated TGV as a potential risk factor for VA deterioration in NF-1-associated and sporadic OPG. Here, NF1 is linked to neoplasm.